Literature DB >> 22002536

A syn-anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well.

Gerrit M Daubner1, Antoine Cléry, Sandrine Jayne, James Stevenin, Frédéric H-T Allain.   

Abstract

SRSF2 (SC35) is a key player in the regulation of alternative splicing events and binds degenerated RNA sequences with similar affinity in nanomolar range. We have determined the solution structure of the SRSF2 RRM bound to the 5'-UCCAGU-3' and 5'-UGGAGU-3' RNA, both identified as SRSF2 binding sites in the HIV-1 tat exon 2. RNA recognition is achieved through a novel sandwich-like structure with both termini forming a positively charged cavity to accommodate the four central nucleotides. To bind both RNA sequences equally well, SRSF2 forms a nearly identical network of intermolecular interactions by simply flipping the bases of the two consecutive C or G nucleotides into either anti or syn conformation. We validate this unusual mode of RNA recognition functionally by in-vitro and in-vivo splicing assays and propose a 5'-SSNG-3' (S=C/G) high-affinity binding consensus sequence for SRSF2. In conclusion, in addition to describe for the first time the RNA recognition mode of SRSF2, we provide the precise consensus sequence to identify new putative binding sites for this splicing factor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22002536      PMCID: PMC3252578          DOI: 10.1038/emboj.2011.367

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  67 in total

Review 1.  Mechanisms of alternative pre-messenger RNA splicing.

Authors:  Douglas L Black
Journal:  Annu Rev Biochem       Date:  2003-02-27       Impact factor: 23.643

2.  New applications of 2D filtered/edited NOESY for assignment and structure elucidation of RNA and RNA-protein complexes.

Authors:  Robert D Peterson; Carla A Theimer; Haihong Wu; Juli Feigon
Journal:  J Biomol NMR       Date:  2004-01       Impact factor: 2.835

Review 3.  Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA.

Authors:  Cyril F Bourgeois; Fabrice Lejeune; James Stévenin
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2004

4.  RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20.

Authors:  Manuel de la Mata; Alberto R Kornblihtt
Journal:  Nat Struct Mol Biol       Date:  2006-10-08       Impact factor: 15.369

5.  Biochemical and NMR study on the competition between proteins SC35, SRp40, and heterogeneous nuclear ribonucleoprotein A1 at the HIV-1 Tat exon 2 splicing site.

Authors:  Houda Hallay; Nicolas Locker; Lilia Ayadi; Delphine Ropers; Eric Guittet; Christiane Branlant
Journal:  J Biol Chem       Date:  2006-09-21       Impact factor: 5.157

6.  Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly.

Authors:  Haihong Shen; Julie L C Kan; Michael R Green
Journal:  Mol Cell       Date:  2004-02-13       Impact factor: 17.970

7.  SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.

Authors:  Alan M Zahler; Christian K Damgaard; Jorgen Kjems; Massimo Caputi
Journal:  J Biol Chem       Date:  2003-12-31       Impact factor: 5.157

8.  Molecular basis of RNA recognition and TAP binding by the SR proteins SRp20 and 9G8.

Authors:  Yann Hargous; Guillaume M Hautbergue; Aura M Tintaru; Lenka Skrisovska; Alexander P Golovanov; James Stevenin; Lu-Yun Lian; Stuart A Wilson; Frédéric H-T Allain
Journal:  EMBO J       Date:  2006-10-12       Impact factor: 11.598

9.  A novel role for shuttling SR proteins in mRNA translation.

Authors:  Jeremy R Sanford; Nicola K Gray; Karsten Beckmann; Javier F Cáceres
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

10.  An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.

Authors:  Pablo Arrisi-Mercado; Maurizio Romano; Andres F Muro; Francisco E Baralle
Journal:  J Biol Chem       Date:  2004-07-07       Impact factor: 5.157

View more
  69 in total

Review 1.  Altered RNA Processing in Cancer Pathogenesis and Therapy.

Authors:  Esther A Obeng; Connor Stewart; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2019-10-14       Impact factor: 39.397

2.  Structural basis of nucleic acid binding by Nicotiana tabacum glycine-rich RNA-binding protein: implications for its RNA chaperone function.

Authors:  Fariha Khan; Mark A Daniëls; Gert E Folkers; Rolf Boelens; S M Saqlan Naqvi; Hugo van Ingen
Journal:  Nucleic Acids Res       Date:  2014-06-23       Impact factor: 16.971

Review 3.  Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures.

Authors:  Jermaine L Jenkins; Clara L Kielkopf
Journal:  Trends Genet       Date:  2017-03-31       Impact factor: 11.639

4.  RNA Bind-n-Seq: Measuring the Binding Affinity Landscape of RNA-Binding Proteins.

Authors:  Nicole J Lambert; Alex D Robertson; Christopher B Burge
Journal:  Methods Enzymol       Date:  2015-05-12       Impact factor: 1.600

Review 5.  Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms.

Authors:  Tariq I Mughal; Omar Abdel-Wahab; Raajit Rampal; Ruben Mesa; Steffen Koschmieder; Ross Levine; Rüdiger Hehlmann; Giuseppe Saglio; Tiziano Barbui; Richard A Van Etten
Journal:  Leuk Lymphoma       Date:  2016-05-31

6.  Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice.

Authors:  Ayana Kon; Satoshi Yamazaki; Yasuhito Nannya; Keisuke Kataoka; Yasunori Ota; Masahiro Marshall Nakagawa; Kenichi Yoshida; Yusuke Shiozawa; Maiko Morita; Tetsuichi Yoshizato; Masashi Sanada; Manabu Nakayama; Haruhiko Koseki; Hiromitsu Nakauchi; Seishi Ogawa
Journal:  Blood       Date:  2017-11-16       Impact factor: 22.113

Review 7.  Spliceosomal factor mutations and mis-splicing in MDS.

Authors:  Courtney E Hershberger; Noah J Daniels; Richard A Padgett
Journal:  Best Pract Res Clin Haematol       Date:  2020-08-01       Impact factor: 3.020

8.  Aberrant RNA Splicing in Cancer.

Authors:  Luisa Escobar-Hoyos; Katherine Knorr; Omar Abdel-Wahab
Journal:  Annu Rev Cancer Biol       Date:  2018-11-28

Review 9.  Splicing factor gene mutations in hematologic malignancies.

Authors:  Borja Saez; Matthew J Walter; Timothy A Graubert
Journal:  Blood       Date:  2016-12-09       Impact factor: 22.113

Review 10.  Regulation of splicing by SR proteins and SR protein-specific kinases.

Authors:  Zhihong Zhou; Xiang-Dong Fu
Journal:  Chromosoma       Date:  2013-03-24       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.